The Advocacy Training SessionThe training for certification includes a
|
The Advocacy Training SessionThe training for certification includes a
|
Award Discussion At Joycelyn Wood’s table waiting for the Banquet to start Gary Nessenbaum, Judith Ostergard and Donna Schoen talk about the conference (l to r) The Nyswander -Dole Award Fondly called “The Marie” after Dr. Nyswander the Dole – Nyswander Award was first presented in 1983 to recognize extraordinary work in the field. Recipients…
The next few years will be important and exciting for methadone maintenance treatment. On May 17, 2001 the oversight of methadone was officially removed from the FDA and handed over to the Center for Substance Abuse Treatment. We are currently in a3-year transition period during which CSAT is slowly setting policy which includes accreditation of…
J. Thomas Payte, M.D. is Medical Director and Founder of Drug Dependence Associates in San Antonio, Texas, Chair of the Maintenance Medications Committee of the American Society of Addiction Medicine and a member of NAMAs Advisory Board. Jeffrey Smith, Ph.D. has a degree is central nervous system pharmacology. Joycelyn Woods, M.A. is President of NAMA….
Most heroin addicts will tell you the high behind methadone is quite inadequate, at least in comparison with the real thing. You may have heard a saying, If God made something better than heroin, He is keeping it to Himself! Almost all opiate addicts like heroin better than methadone. The most seasoned staff people at…
NAMA Organizational Meeting Monday, October 8th, 7 P.M. Chairs Jo Sotheran, NAMA Board of Directors (Treasurer) Joycelyn Woods, NAMA Board of Directors (President) As meeting starts Joycelyn Woods looks on over the shoulders of Tony Scro (NAMA Grievance Coordinator), James DePasquale (Long Island NAMA) and Donna Schoen (LIJ Patient Committee). Jo Sotheran introduces the reasons…
Policy Statement Number 7 January 1997 Methadone treatment has been in existence now for over thirty years returning to society more productive individuals than any other treatment modality. Yet, despite this success it is disparaged and misunderstood which has translated into bias and discrimination not only for the consumer of the treatment as even those…